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expanded at equal rates. This model holds that TCR reported. A demonstration that the relative avidities of
affinity in the immune response matters, but only up to the postimmune T cell CDR3 subsets mirrored their pre-
a point, and beyond a certain level more is not better. immune counterparts would rule this possibility out.
With this provocative idea in mind, it is worth examin- The unexpected findings of Malherbe et al. (2004) fo-
ing some of the assumptions underlying the interpreta- cus our attention on an issue of fundamental importance
tion of the results. Scatchard plots were used to demon- in T cell biology: how does the affinity/avidity of individu-
strate that preimmune 2B4 T cells have lower affinity ally-expressed TCRs “shape” the adaptive immune re-
than 5C.C7 T cells for MCC/I-Ek. One would expect a sponse? The work argues for the primacy of affinity/
wide range of affinities in both groups, because the avidity rather than off-rate in determining the robustness
transgenic  chain can form productive antigen binding of T cell expansion. One of the implications of the affinity
heterodimers with many different V11-containing part- threshold model is that receptor diversity is maintained
ners. Yet the Scatchard analyses show a single linear once a sufficient TCR affinity for ligand is attained. That
regression line for each group, with no evidence of di- is, in cases such as 5C.C7 T cells where multiple clono-
verse affinities. A possible inference from this is that the types satisfy the minimum affinity requirement, the im-
flow cytometry-based method of determining bound/ mune response will not come to be dominated by high
free tetramers detects only cells with the highest affinity. affinity T cells descended from one or a few progenitors.
If so, although one might be able to conclude that best Antigen-specific clonal diversity might be expected to
2B4 T cells have perhaps 2-fold less affinity than the confer certain advantages, such as the maintenance
best 5C.C7 T cells, one does not know the distribution of protection against antigenic variants that may arise
or range of affinities within each group. Perhaps more during the course of an infection. The thought-provoking
of an issue is that tetramer staining cannot actually quan- findings in this sophisticated analysis are sure to spark
titate TCR “affinity.” Rather, because of the multimeric another round of studies assessing the quantitative rela-
nature of tetramer binding, it tells us something about tionships between TCR affinity and biologically rele-
relative “avidities.” This is clear simply from the observa- vant responses.
tion that the affinity of the monomeric 2B4  TCR mea-
sured by surface plasmon resonance is approximately
Jonathan D. Ashwell60 M (Matsui et al., 1994), whereas the “affinity” of cell
Laboratory of Immune Cell Biologysurface 2B4  TCRs measured by tetramer staining is
National Cancer Instituteapproximately 60 nM (Savage et al., 1999), a 1000-fold
National Institutes of Healthdifference. Although it seems reasonable that the rela-
Bethesda, Maryland 20892tionship between affinity and avidity should roughly cor-
relate (higher affinities yielding higher avidities), it will
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Apoptosis is a mechanism for removal of unwanted, old,Fingering IL-12
or damaged cells. As such, it involves destruction of thewith Apoptotic Cells nuclear and replicative functions of the cell as well as
exposure on the cell surface of recognition structures
that mediate clearance by a unique form of phagocyto-
sis. Importantly, apoptotic cell removal within tissues
is normally “quiet” and noninflammatory. In fact, theExposure of phosphatidylserine on the surface of apo-
recognition of apoptotic cells appears to induce activeptotic cells contributes to their removal in situ by quiet,
anti-inflammatory and anti-immunogenic processes, al-noninflammatory, and nonimmunogenic mechanisms.
though the ligands, receptors, and mediators involvedIn this issue of Immunity, Kim et al. (2004) describe a
in these suppressive activities are incompletely under-completely new mechanism for this effect that in-
stood. Much emphasis has been placed on the effectsvolves a novel zinc finger nuclear factor that inhibits
IL-12 production. of exposed phosphatidylserine (PS) on the apoptotic
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cell and its ability to induce in responding cells the anti- for this combination of stimuli—in particular does it also
apply to the complex feedback interactions betweeninflammatory and anti-immunogenic molecule TGF- as
well as anti-inflammatory prostanoids, and in some IFN and IL-12 along with TNF and even TGF-, the
latter of which is also an effective suppressor of IL-12?cases IL-10. However, the article by Kim et al. (2004) in
this issue of Immunity suggests a new mechanism for IL-12 itself induces IFN and has long been implicated
in T helper 1 lymphocyte differentiation (Trinchieri et al.,the modulation of inflammatory and immunologic pro-
cesses by apoptotic cells, driven by PS, but independent 2003). It has been shown to participate in mediating
resistance to intracellular pathogens. Because someof TGF- or other previously implicated anti-inflamma-
tory mediators. Their studies have focused on the heter- parasites may employ the normal PS recognition re-
sponse as a mechanism for entering macrophages andodimeric proinflammatory and proimmunogenic cyto-
kine IL-12 and show that apoptotic cells and PS simultaneously suppressing inflammatory (and possibly
immunological) responses (de Freitas Balanco et al.,liposomes suppress generation of the intact p70 form
as well as of both p70 subunits (p35 and p40) from IFN 2001), whereas others thrive in an environment con-
taining apoptotic cells (Freire-de-Lima et al., 2000), aand LPS stimulated macrophages. An investigation of
the mechanism for this suppression by analysis of the direct effect in inhibiting production of IL-12 could be
an additional component of such subversive pathways.p35 promoter revealed a critical role for a new zinc finger
nuclear factor that Kim et al. (2004) named GC-BP for On the other hand, the role of IL-12 in mediating autoim-
mune reactions might also implicate effects of apoptoticits ability to bind to the GCF element between 13
to19 of the promoter. GC-BP appeared to be constitu- cells. Defects in clearance of apoptotic cells have been
found in systemic lupus erythematosus (Baumann et al.,tively expressed in the various macrophages examined
and was suggested on the basis of mutational analysis 2002). This suggests that in the absence of clearance of
these apoptotic cells, postapoptotic cytolysis releasesto act after decreased phosphorylation of one of two
candidate tyrosines after stimulation by apoptotic cells. autoantigens that might diminish the ability to suppress
IL-12 production. Increased levels of this cytokine areImportantly, whereas apoptotic cells and PS liposomes
also inhibited production of the IL-12 p40 subunit, this often seen in SLE. Other autoimmune responses have
also been shown to be enhanced in the absence of IL-effect was independent of GC-BP, which in this study,
appeared to be specific for p35. 12 p35 (Gran et al., 2002) and might be similarly en-
hanced by increased exposure at the site to apoptoticA number of fascinating questions arise out of this
important work. The primary macrophages and macro- cells or PS. In such circumstances, it has been sug-
gested that IL-23 is enhanced and plays a contributingphage cell lines examined did not express IL-12 consti-
tutively, and in all cases the stimulus used was the com- role. IL-23 is closely related to IL-12, representing a
heterodimer of p40 and p19 instead of p40 and p35.bination of IFN and LPS, which induces a “classically”
activated macrophage. Since GC-BP protein levels did The effects of apoptotic cells and GC-BP on p19 and
IL-23 were not examined by Kim et al. (2004). Thesenot change in amount or in the cytoplasmic to nuclear
distribution in response to these stimuli, the increased examples all bring to the fore issues of balance in normal
tissue homeostasis. Each day, large numbers of cells inphosphorylation of GC-BP seen with IFN and LPS is
consistent with a positive role for tyrosine phosphory- mammals become apoptotic, are removed, and then are
replaced. The effects of these ongoing processes arelated GC-BP in the induction of IL-12. In support of this
hypothesis, exposure of the macrophages to apoptotic undoubtedly different at local sites within the body but
may critically alter the regulation of IL-12 and other mol-cells diminished the level of GC-BP phosphorylation
back to the baseline level, and it simultaneously blocked ecules involved in the normal immune response and
host defense.the stimulated production of IL-12. However, siRNA-
mediated knockdown of GC-BP mRNA levels did not While most studies of apoptotic cell clearance and
their effects have focused on macrophages and den-alter production of IL-12 (or the p35 mRNA) that was
observed after macrophage activation, and overexpres- dritic cells, most cell types, in fact, can recognize and
ingest apoptotic cells and respond by generating anti-sion of GC-BP was suppressive. These observations
support a direct suppressive effect of GC-BP. At this inflammatory molecules and/or inhibiting production of
proinflammatory mediators. Kim et al. (2004) commentpoint, it is not clear what proportion of GC-BP is consti-
tutively phosphorylated, nor is the role of phosphoryla- on the need to explore possible regulatory effects of
GC-BP in other cells and on other molecules. The abilitytion/dephosphorylation on binding of the GC-BP to the
p35 promoter or on the overall PS-induced regulation. of PS on apoptotic cells to stimulate the production of
active TGF- appears to be widespread on different cellIs the baseline phosphorylation all on Tyr168, which
is not critical for suppression, and the increase with types. TGF- itself acts to block inflammation by primary
effects on NF-B driven pathways, but there are a num-activation and decrease with apoptotic cells localized
to the Tyr15, which was shown by mutational analysis ber of other effects of apoptotic cells that do not appear
to depend on autocrine/paracrine effects of TGF- (in-to be needed for the suppression? Does GC-BP in the
Tyr15 de-phosphorylated state maintain the IL-12 p35 cluding, for example, the upregulation of PPAR and
15-lipoxygenase), which, while not necessarily drivenpromoter in a baseline suppressed state so that phos-
phorylation after cell activation releases this suppres- by GC-BP, do suggest multiple mechanisms for main-
taining a quiet response during removal of normally gen-sion, thereby allowing transcription? If indeed tyrosine
phosphorylation is involved in the regulation of GC-BP- erated apoptotic cells. Finally, it seems highly likely that
recognition signals other than PS will also modulatemediated repression of IL-12, does PS recognition block
IFN and LPS induced protein kinase activation or does the inflammatory consequences during this removal of
apoptotic cells.it stimulate a phosphatase? How selective is the effect
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